483866763
31 Jan 2023
France Dupixent dupilumab recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis, France
Severity: Notice
Message: Undefined variable: region
Filename: views/login_detail_view_new_V1.php
Line Number: 393
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.